STUDIES ON THE DEFECT WHICH CAUSES ABSENCE OF DECAY ACCELERATING FACTOR (DAF) FROM THE PERIPHERAL-BLOOD CELLS OF AN INDIVIDUAL WITH THE INAB PHENOTYPE
STUDIES ON THE DEFECT WHICH CAUSES ABSENCE OF DECAY ACCELERATING FACTOR (DAF) FROM THE PERIPHERAL-BLOOD CELLS OF AN INDIVIDUAL WITH THE INAB PHENOTYPE
复制标题
DOI:
10.1042/bj2610489
复制
发表时间:
1989-07-15
影响因子:
4.1
通讯作者:
ANSTEE, DJ
中科院分区:
文献类型:
--
作者:
TATE, CG;UCHIKAWA, M;ANSTEE, DJ
1. We have studied the peripheral blood cells of an individual with the Inab phenotype who is deficient in decay accelerating factor (DAF). 2. In contrast with the situation in paroxysmal nocturnal haemoglobinuria, membranes from peripheral blood cells of the Inab phenotype individual lack DAF, but retain the other glycosylphosphatidylinositol-linked proteins acetylcholinesterase and LFA-3 3. Unlike normal Epstein-Barr-virus-transformed lymphoblastoid cell lines (EBV-LCL), DAF was not expressed on EBV-LCL derived from peripheral blood lymphocytes of the Inab individual. 4. No differences in the DAF gene of normal and Inab phenotype individuals could be detected by Southern blotting studies. 5. EBV-LCL derived from the Inab individual had a gross reduction in the level of DAF mRNA compared with normal EBV-LCL. 6. Our results suggest that the DAF gene in the Inab phenotype contains a mutation which affects the transcription or processing of DAF mRNA.